Milestone Pharmaceuticals amends ATM sales agreement with Jefferies to up to $77.8M

Milestone Pharmaceuticals Inc.

Amended Open Market Sale Agreement replaces prior $50M facility; total capacity increased to $77.8M including ~$2.8M already sold.
Common shares sold at-the-market via Jefferies; company pays 3.0% commission on gross proceeds.
Prospectus supplement to be filed under existing S-3 shelf registration (File No. 333-283162).
Company not obligated to sell any shares; agreement may be terminated early by either party.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.